Fredrik Laestadius

837 total citations
3 papers, 137 citations indexed

About

Fredrik Laestadius is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Fredrik Laestadius has authored 3 papers receiving a total of 137 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 1 paper in Surgery and 1 paper in Oncology. Recurrent topics in Fredrik Laestadius's work include Prostate Cancer Treatment and Research (2 papers), Prostate Cancer Diagnosis and Treatment (1 paper) and Cancer, Lipids, and Metabolism (1 paper). Fredrik Laestadius is often cited by papers focused on Prostate Cancer Treatment and Research (2 papers), Prostate Cancer Diagnosis and Treatment (1 paper) and Cancer, Lipids, and Metabolism (1 paper). Fredrik Laestadius collaborates with scholars based in Sweden, Ireland and Finland. Fredrik Laestadius's co-authors include Maccon Keane, John McCaffrey, Timo Joensuu, Ray McDermott, R. Asola, Paul Nyandoto, Akseli Hemminki, Pirkko‐Liisa Kellokumpu‐Lehtinen, Tiina Tasmuth and Heikki Joensuu and has published in prestigious journals such as Journal of Clinical Oncology and The Lancet Oncology.

In The Last Decade

Fredrik Laestadius

2 papers receiving 131 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fredrik Laestadius Sweden	2	121	39	38	38	32	3	137
Sunil Parimi Canada	7	91 0.8×	44 1.1×	57 1.5×	37 1.0×	10 0.3×	18	142
Louis Marie Dourthe France	2	104 0.9×	31 0.8×	92 2.4×	24 0.6×	21 0.7×	5	180
Robin Millman United Kingdom	2	91 0.8×	27 0.7×	16 0.4×	31 0.8×	11 0.3×	2	95
Alex Hoyle United Kingdom	6	127 1.0×	66 1.7×	27 0.7×	36 0.9×	12 0.4×	13	146
Alison Yan Zhang Australia	6	118 1.0×	86 2.2×	47 1.2×	18 0.5×	6 0.2×	18	146
O. B. Kаryakin Russia	5	68 0.6×	29 0.7×	43 1.1×	28 0.7×	6 0.2×	29	105
Yuchao Ni China	8	118 1.0×	17 0.4×	40 1.1×	42 1.1×	5 0.2×	26	176
Martín Lázaro-Quintela Spain	9	84 0.7×	13 0.3×	89 2.3×	22 0.6×	7 0.2×	20	170
Isabelle Rieger France	4	68 0.6×	33 0.8×	26 0.7×	17 0.4×	13 0.4×	7	96
N. Antoniou Greece	7	66 0.5×	12 0.3×	32 0.8×	13 0.3×	10 0.3×	15	125

Countries citing papers authored by Fredrik Laestadius

Since Specialization

Citations

This map shows the geographic impact of Fredrik Laestadius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fredrik Laestadius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fredrik Laestadius more than expected).

Fields of papers citing papers by Fredrik Laestadius

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fredrik Laestadius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fredrik Laestadius. The network helps show where Fredrik Laestadius may publish in the future.

Co-authorship network of co-authors of Fredrik Laestadius

This figure shows the co-authorship network connecting the top 25 collaborators of Fredrik Laestadius. A scholar is included among the top collaborators of Fredrik Laestadius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fredrik Laestadius. Fredrik Laestadius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Bompas, Emmanuelle, Emilie Bogart, Fredrik Laestadius, et al.. (2017). Predictors for malignant tissue (MT) in residual masses (RM) of non-seminomatous germ cell tumors (NSGCT) treated by chemotherapy (CT) before surgery.. Journal of Clinical Oncology. 35(6_suppl). 405–405.

2.

Harmenberg, Ulrika, Timo Joensuu, Ray McDermott, et al.. (2014). Triweekly docetaxel versus biweekly docetaxel as a treatment for advanced castration resistant prostate cancer: Quality of life analysis.. Journal of Clinical Oncology. 32(4_suppl). 23–23. 2 indexed citations

3.

Kellokumpu‐Lehtinen, Pirkko‐Liisa, Ulrika Harmenberg, Timo Joensuu, et al.. (2013). 2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial. The Lancet Oncology. 14(2). 117–124. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact